SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.20549
FORM 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
of the Securities Exchange Act of 1934
25 September, 2008
LLOYDS TSB GROUP plc
(Translation of registrant's name into English)
5th Floor
25 Gresham Street
London
EC2V 7HN
United Kingdom
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual
reports
under cover Form 20-F or Form 40-F.
Form 20-F..X..Form 40-F.....
Indicate by check mark whether the registrant by furnishing the information
contained in this Form is also thereby furnishing the information to the
Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes .....No ..X..
If "Yes" is marked, indicate below the file number assigned to the
registrant in connection with Rule
12g3-2(b): 82- ________
Index to Exhibits
Item
No. 1 Regulatory News Service
Announcement, dated 25 September, 2008
re:
Rule 2.10 Announcement
Disclosure in accordance with
Rule 2.10 of the City Code
In accordance with Rule 2.10 of the
City Code on Takeovers and Mergers, Lloyds TSB Group plc confirms that it
has in issue 5,972,590,762 ordinary shares of 25 pence each with voting
rights.
The ISIN reference for the ordinary
shares is GB0008706128.
The company holds no treasury
shares.
Lloyds TSB Group plc shares are
traded in the USA through an NYSE-listed sponsored ADR facility, with The
Bank of New York as the depositary.
The ADRs are traded on the New York
Stock Exchange under the symbol LYG.
The CUSIP number is 539439109 and the
ratio of ADRs to ordinary shares is 1:4.
The total number of shares issued by
Lloyds TSB Group plc with voting rights which are exercisable in all
circumstances at general meetings is therefore 5,972,590,762. This figure
may be used by shareholders to determine the percentage of issued share
capital they hold in the Company and if they are required to notify their
interest in, or a change in their interest in, the Company under the FSA's
Disclosure and Transparency Rules.
For further
information:-
Director of Investor
Relations
michael.oliver@ltsb-finance.co.uk
Senior Manager, Investor
Relations
douglas.radcliffe@ltsb-finance.co.uk
Senior Manager, Media
Relations
amy.mankelow@lloydstsb.co.uk
Dealing Disclosure
Requirements
Under the provisions of Rule 8.3 of
the Takeover Code (the "
"), if any person is, or becomes,
"interested" (directly or indirectly) in 1% or more of any class of
"relevant securities" of Lloyds TSB Group plc, all dealings in any
"relevant securities" of that company (including by means of an option in
respect of, or a derivative referenced to, any such "relevant securities")
must be publicly disclosed by no later than 3:30pm (London time) on the
London business day following the date of the relevant transaction. This
requirement will continue until the date on which the offer becomes, or is
declared, unconditional as to acceptances, lapses or is otherwise withdrawn
or on which the "offer period" otherwise ends.
If two or more persons act
together pursuant to an agreement or understanding, whether formal or
informal, to acquire an "interest" in "relevant securities" of Lloyds TSB
Group plc, they will be deemed to be a single person for the purpose of
Rule 8.3.
Under the provisions of Rule 8.1 of
the Code, all "dealings" in "relevant securities" of Lloyds TSB Group plc
by Lloyds TSB Group plc or any of its "associates", must be disclosed by no
later than 12:00 noon (London time) on the London business day following
the date of the relevant transaction.
A disclosure table, giving details of
the companies in whose "relevant securities" "dealings" should be
disclosed, and the number of such securities in issue, can be found on the
Takeover Panel's website at www.thetakeoverpanel.org.uk.
"Interests in securities" arise, in
summary, when a person has long economic exposure, whether conditional or
absolute, to changes in the price of securities.
In particular, a person will be
treated as having an "interest" by virtue of the ownership or control of
securities, or by virtue of any option in respect of, or derivative
referenced to, securities.
Terms in quotation marks are defined
in the Code, which can also be found on the Panel's
website.
If you are in any doubt as to whether
or not you are required to disclose a "dealing" under Rule 8, you should
consult the Panel.
FORWARD LOOKING
STATEMENTS
This announcement contains forward
looking statements with respect to the business, strategy and plans of the
Lloyds TSB Group, its current goals and expectations relating to
its future financial condition and performance. By their nature, forward
looking statements involve risk and uncertainty because they relate to
events and depend on circumstances that will occur in the future. The
Group's actual future results may differ materially from the results
expressed or implied in these forward looking statements as a result of a
variety of factors, including UK domestic and global economic and business
conditions, risks concerning borrower credit quality, market related risks
such as interest rate risk and exchange rate risk in its banking business
and equity risk in its insurance businesses, changing demographic trends,
unexpected changes to regulation, the policies and actions of governmental
and regulatory authorities in the UK or jurisdictions outside the UK,
including other European countries and the US,
exposure to legal proceedings or
complaints,
changes in customer preferences,
competition and other factors. Please refer to the latest Annual Report on
Form 20-F filed with the US Securities and Exchange Commission for a
discussion of such factors. The forward looking statements contained in
this announcement are made as at the date of this announcement, and the
Group undertakes no obligation to update any of its forward looking
statements.
Signatures
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.
LLOYDS TSB GROUP plc
(Registrant)
By: M D Oliver
Name: M D Oliver
Title: Director of Investor Relations
Date: 25 September, 2008